Vitis Spp Injection, Solution
NDC 0268-6139
Product Information
Vitis Spp is a BLA-approved product labeled by Alk-abello, Inc.. This medication is typically used as a allergens [cs]. It is supplied as a injection, solution for percutaneous administration. This product entry covers the primary NDC 0268-6139 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0268-6139?
What are the uses of this product?
What are Active Ingredients of this product?
- GRAPE .1 g/mL - A plant genus in the family Vitaceae. It is a woody vine cultivated worldwide. It is best known for grapes, the edible fruit and used to make WINE and raisins.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- GRAPE (UNII: 6X543N684K)
- GRAPE (UNII: 6X543N684K) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM METABISULFITE (UNII: 4VON5FNS3C)
- PHENOL (UNII: 339NCG44TV)
- GLYCERIN (UNII: PDC6A3C0OX)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1006347 - arabica coffee bean allergenic extract 100 MG/ML Injectable Solution
- RxCUI: 1006347 - arabica coffee bean allergenic extract 0.1 GM/ML Injectable Solution
- RxCUI: 1011078 - pineapple allergenic extract 100 MG/ML Injectable Solution
- RxCUI: 1011078 - pineapple allergenic extract 0.1 GM/ML Injectable Solution
- RxCUI: 2274705 - Atlantic halibut allergenic extract 100 MG/ML Injectable Solution
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.